VeriMomIs tetradecyl aminobutyroylvalylaminobutyric urea trifluoroacetate safe during pregnancy?
No harmonised CLP classification, no SCCS or CIR safety assessment, and no peer‑reviewed reproductive or developmental studies located for this CAS (934368-60-2). Manufacturer/product literature (DSM Syn‑HYCAN) describes it as a tripeptide cosmetic active; regulatory/toxicology databases (EPA CompTox, supplier pages) list identity but provide no reproductive hazard. In absence of authoritative evidence of reproductive toxicity, default score is 0. Sources: DSM product sheet, EPA CompTox, lack of entries in SCCS/CIR/ECHA Annex VI.
Pregnancy-safe products containing tetradecyl aminobutyroylvalylaminobutyric urea trifluoroacetate
Related ingredients
Frequently asked questions
- Is tetradecyl aminobutyroylvalylaminobutyric urea trifluoroacetate safe during pregnancy?
- No harmonised CLP classification, no SCCS or CIR safety assessment, and no peer‑reviewed reproductive or developmental studies located for this CAS (934368-60-2). Manufacturer/product literature (DSM Syn‑HYCAN) describes it as a tripeptide cosmetic active; regulatory/toxicology databases (EPA CompTox, supplier pages) list identity but provide no reproductive hazard. In absence of authoritative evidence of reproductive toxicity, default score is 0. Sources: DSM product sheet, EPA CompTox, lack of entries in SCCS/CIR/ECHA Annex VI.
- Is tetradecyl aminobutyroylvalylaminobutyric urea trifluoroacetate safe while breastfeeding?
- No data located showing lactational transfer, mammary toxicity, or reproductive system effects. No SCCS/CIR opinion or harmonised hazard for this ingredient. Therefore default hazard/mechanism = 0 and exposure from topical cosmetic use is considered negligible based on peptide structure and marketed aqueous/glycerin formulations. Sources: DSM Syn‑HYCAN product literature, EPA CompTox, PubMed search (no relevant studies found).
- Is tetradecyl aminobutyroylvalylaminobutyric urea trifluoroacetate safe for baby skin?
- No infant-specific toxicity or dermal absorption studies were found. Peptide active (high MW, water‑soluble glycerin formulations) suggests low systemic absorption in adults (adult e=0). Per scoring rules, because adult absorption is not demonstrably zero and infant skin has higher permeability, exposure for 0–3 yr is conservatively increased by +1 to e=1. No data were found to increase hazard (h) or mechanism (m) scores for infants. Sources: DSM Syn‑HYCAN brochure, EPA CompTox, EWG listing noting concern but not providing reproductive/infant data.
- How does VeriMom score tetradecyl aminobutyroylvalylaminobutyric urea trifluoroacetate?
- VeriMom scores tetradecyl aminobutyroylvalylaminobutyric urea trifluoroacetate at 100/100 (no known risks) based on EU CosIng status, ECHA hazard classifications, and peer-reviewed PubMed studies. Our scoring pipeline is fully transparent.
- What are pregnancy-safe alternatives to tetradecyl aminobutyroylvalylaminobutyric urea trifluoroacetate?
- See our curated list of pregnancy-safe alternatives to tetradecyl aminobutyroylvalylaminobutyric urea trifluoroacetate based on similar function and a no-known-risks safety band.
Check every label in 2 seconds
Get VeriMom free — scan any product and see the pregnancy safety score instantly.
Medical Disclaimer
This information is for educational purposes only and does not constitute medical advice. Safety scores are based on publicly available data and may not reflect all risks. Always consult your healthcare provider before using any product during pregnancy or breastfeeding.